U.S. Construction Stock News

Guardant Health (GH) is back in focus after the U.S. Food and Drug Administration approved its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s newly approved HERNEXEOS lung cancer therapy. See our latest analysis for Guardant Health. The recent FDA approval arrives as momentum in Guardant Health's stock has been strong, with a 90-day share price return of 55.58% and a 1-year total shareholder return of 174.69%. This indicates that investors are reassessing...

Kaspi.kz (NasdaqGS:KSPI) has drawn fresh attention after confirming a special cash dividend, with an ex dividend date tied to a payout of $1.74266 per share, together with a KZT 850 distribution per common share. See our latest analysis for Kaspi.kz. Against this backdrop, Kaspi.kz’s share price has moved to $86.0, with a 1 day share price return of 2.99% and a 7 day share price return of 3.28%. The 30 day share price return is down 6.05% and the 90 day share price return is 15.97%, alongside...

Shift4 Payments (FOUR) recently drew fresh attention after partnering with Lydian to let merchants accept Tether (USDT) while still settling in local currency, broadening its crypto offering alongside expectations for event driven payment volumes. See our latest analysis for Shift4 Payments. Despite the crypto partnership and expectations around event driven volumes, Shift4 Payments’ share price has been volatile, with a 1 day share price return of 14.35% and a year to date share price return...

Jiayin Group (NasdaqGM:JFIN) has wrapped up FY 2025 with fourth quarter revenue of C¥1,090.2 million and basic EPS of C¥1.95, alongside trailing 12 month revenue of C¥6.2 billion and EPS of C¥29.41, all against a backdrop of 45.4% trailing earnings growth over the past year. Over recent periods the company has seen quarterly revenue move from C¥1,404.5 million and EPS of C¥5.18 in Q4 2024 to C¥1,775.6 million and EPS of C¥10.11 in Q1 2025, before reaching the latest Q4 print. This sets the...

In June 2026, a Delaware jury found that Amgen and its subsidiary Teneobio willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704 in damages and opening the door to a potential trebling of the award to about US$60.61 million. The verdict places fresh attention on Amgen’s exposure to intellectual property disputes around its antibody discovery technology, raising questions about legal risk management and potential future royalty or licensing obligations. We’ll...

Automatic Data Processing (ADP) is back in focus after its latest employment data showed a pickup in U.S. private sector hiring for the first time since early May, alongside a recent analyst rating upgrade. See our latest analysis for Automatic Data Processing. At a share price of $219.86, Automatic Data Processing has seen short term share price momentum cool, with a 30 day share price return that declined 2.4%, while a 90 day share price return of 7.5% and a 5 year total shareholder return...

Cerebras Systems stock performance snapshot after recent moves Cerebras Systems (CBRS) has drawn attention after a sharp pullback, with the stock down 19.5% over the past day, 14.6% over the past week, and 28.9% over the past month. With year-to-date performance down 41.4% and the last close at $182.41, investors are reassessing how Cerebras Systems’ AI infrastructure business and current valuation align with their risk tolerance and time horizon. See our latest analysis for Cerebras...

In mid-June 2026, Applied Materials introduced its SENZ integrated visual platform for AI-powered smart glasses, launched new chipmaking systems for advanced 3D logic and memory, and opened a new US$500 million Tampines Campus in Singapore that more than doubles its local cleanroom capacity. These moves extend Applied Materials beyond core wafer equipment into augmented reality optics while also deepening its role in AI infrastructure manufacturing through expanded high-volume production...

Targa Resources (TRGP) has drawn investor attention after its stock closed at $266.32, with recent returns mixed between the past month and past 3 months, and a year-to-date gain alongside longer-term strength. See our latest analysis for Targa Resources. Over the past year, Targa Resources has combined strong momentum, with a 42.59% year to date share price return and a very large 5 year total shareholder return of 564.25%, even though the 30 day share price return is down 3.77%, suggesting...

Boeing (NYSE:BA) has secured a fixed-price incentive contract to deliver and support two MUOS satellites. The MUOS deal expands Boeing’s role in military satellite communications and adds to its long-term government contract portfolio. The contract focuses on critical communications infrastructure for defense customers, with multi year execution and support. Boeing’s MUOS contract comes as the company continues to balance its commercial aviation activities with a presence in defense and...

If you are wondering whether Waters is priced fairly or if the stock leans more toward opportunity or caution, this article walks through the key valuation checks that may matter most to you. Waters recently closed at US$369.18, with returns of 3.4% over the last week, 7.8% over the last month, a decline of 3.3% year to date, and a 5.5% gain over the past year. This provides useful context before considering what the current price might imply. Recent coverage has described Waters as a mature...

How Sysco Stock Has Been Performing Recently Sysco (SYY) has drawn fresh attention after a recent stretch of gains, with the stock up about 2% over the past week and around 6% over the past month, while the past 3 months show a slight decline. See our latest analysis for Sysco. Looking beyond the recent bounce, Sysco’s share price return of 10.97% year to date and a 1-year total shareholder return of 10.47% point to steady but not explosive momentum, suggesting sentiment has improved rather...

United Therapeutics (UTHR) is back in focus after reporting first quarter results with lower year-on-year revenue and a meaningful earnings miss versus analyst expectations, which weighed on investor confidence and pressured the stock. See our latest analysis for United Therapeutics. Beyond the weak first quarter, United Therapeutics’ share price has drifted, with a 30 day share price return of a 3.24% decline and a modest 3.28% gain over 90 days, while a 1 year total shareholder return of...

Astera Labs, Inc. was added to the Nasdaq-100 Index on 22 June 2026, reflecting its growing role in semiconductor connectivity solutions for cloud and AI infrastructure, including PCIe, CXL and Ethernet products. This index inclusion has amplified investor focus on Astera Labs’ high-growth AI infrastructure exposure and elevated valuation multiples, against a backdrop of decelerating growth rates flagged by institutional investors. We’ll now examine how joining the Nasdaq-100, and the...

Dell Technologies (DELL) is back in focus after reporting very strong fiscal Q1 2027 results and unveiling its Vera Rubin based PowerEdge XE8812 AI server, a combination that has refocused attention on the stock’s AI-driven story. See our latest analysis for Dell Technologies. The Vera Rubin based PowerEdge launch and strong fiscal Q1 2027 numbers have coincided with powerful momentum in Dell Technologies, with a 30 day share price return of 47.04% and a year to date share price return of...

Otis Worldwide (OTIS) is in focus after Otis Elevator Company India appointed Pulkit Goyal as its new Chief Financial Officer. This leadership move comes as global elevator peers consider significant corporate combinations. See our latest analysis for Otis Worldwide. Otis Worldwide’s share price is at US$72.63 after a 1-day share price return of 1.23%. However, the year-to-date share price return is down 17.78% and the 1-year total shareholder return has declined 23.31%, suggesting recent...

Humana Inc. announced that it was selected by the Illinois Department of Healthcare and Family Services to serve Medicaid members statewide under HealthChoice Illinois, with its HealthChoice plan expected to begin in January 2027 across all 102 counties. At the same time, Pzena Investment Management’s comments on Medicare Advantage rate uncertainty and benefit sustainability have sharpened investor focus on Humana’s core government-sponsored health plans. Next, we’ll examine how Illinois’...

War spending is back in the headlines, with the White House requesting $87.6b in supplemental funding tied to the Iran conflict, including $21b aimed at Defense Department capabilities and munitions procurement. That kind of policy move can quickly reshape expectations for companies exposed to US defense budgets, while political pushback and deficit concerns add extra policy and market risk. This article breaks down three stocks that are closely tied to this news, explaining how the proposed...

EchoStar plans to change its Nasdaq stock ticker from SATS to ECHO. The new ticker is scheduled to take effect on June 24, 2026. The move is intended to align the NasdaqGS:SATS listing with EchoStar’s broader global connectivity focus. EchoStar sits at the intersection of satellite infrastructure and wider connectivity services, making the ticker shift more than a cosmetic update. As the company works to position itself as a broader global connectivity provider, the move away from a ticker...

Blackstone Mortgage Trust recently declared a US$0.47 per share second-quarter 2026 dividend, payable on July 15, 2026, to shareholders of record as of June 30, 2026. At the same time, a US$343 million loan tied to Chicago’s One South Wacker office tower has entered default, underscoring ongoing stress in office-backed commercial mortgages despite this maintained dividend payout. We’ll now examine how the One South Wacker loan default could influence Blackstone Mortgage Trust’s investment...

How Box’s Recent Returns Set Up a Valuation Conversation Box has had a mixed share price record that sets the stage for a closer look at what investors may be paying for today versus what they are getting in terms of fundamentals and future potential. Over the last year, the stock is down 25.4%, with a year to date decline of 11.7% and a 30 day return that is down 1.7%, while the last 7 days show a 2.1% gain, which may catch the eye of investors watching for shifting sentiment. News flow...

Universal (UVV) is back in focus after its latest quarter showed higher year-over-year revenue and net profit, alongside a rise in institutional ownership as firms like BlackRock and Invesco increased their positions. See our latest analysis for Universal. At a share price of $52.84, Universal’s recent 1-month share price return is down 3.08%, while the 3-year total shareholder return of 27.92% points to steadier results over a longer period as institutions increase their exposure. If this...

Dave (DAVE) is back on investor radar after a series of earnings surprises over the past four quarters, supported by recent upward earnings estimate revisions that have contributed to a stronger tone in market sentiment. See our latest analysis for Dave. At a recent share price of $314.44, Dave has seen strong momentum, with a 1 day share price return of 10.01%, a 30 day share price return of 37.63% and a 1 year total shareholder return of 46.44%. The very large 3 year total shareholder...

Mueller Water Products, Inc. recently announced that Senior Vice President and Chief Human Resources Officer Todd P. Helms will leave the company effective September 1, 2026, then serve as a senior advisor under a consulting agreement through September 30, 2026 to support the transition. This leadership change comes as Mueller reports rising operating margins, strong earnings per share growth, and expanding free cash flow, underpinned by resilient demand for its water management and leak...